Instil Bio, Inc. Other Receivables, Net, Current
Instil Bio, Inc. (TIL) had Other Receivables, Net, Current of $484.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Notes › Nontrade Receivables
us-gaap:OtherReceivablesNetCurrent · last filed 2021-11-15
- 2021-09-30: Other Receivables, Net, Current $484.00K.
- 2021-06-30: Other Receivables, Net, Current $397.00K.
- 2021-03-31: Other Receivables, Net, Current $242.00K.
- 2020-12-31: Other Receivables, Net, Current $1.80M.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2021-09-30 | $484.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $397.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $242.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.80M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |